Background/Aims: α-Klotho is a circulating factor with well-documented anti-aging properties; however, the central role of α-Klotho in metabolism remains largely unexplored. We aimed to investigate the potential role of central α-klotho as a novel regulator of energy balance and glucose homeostasis.

Methods: Central administration of α-klotho was performed by using intracerebroventricular (ICV) injection for seven days in diet-induced obesity (DIO) and streptozotocin-injected (STZ) mice. hrNPY-GFP reporter mice were utilized for electrophysiology and immunofluorescent staining experiments to investigate the effects of α-klotho on NPY/AgRP neurons. To determine the mechanism/s of hypothalamic α-klotho, we used GT1-7 immortal hypothalamic cells in vitro along with ICV administration of fibroblast growth factor receptor 1 (FGFR1) antagonist in vivo.

Results: Central α-klotho administration decreased food intake and improved glucose profiles in DIO and STZ mice. Liver lipid content and gluconeogenic gene expression were also reduced. Electrophysiology and immunofluorescent staining revealed AgRP/NPY neurons exhibit hyperpolarization and reduced firing rate in response to α-klotho treatment. These effects are, at least partially, due to increased magnitude of mIPSC’s. In vitro, α-klotho blunted serum-starvation-induced AgRP gene expression and increased phosphorylation of ERK44/42, AKTser473, and Foxo1ser256. These downstream effects were abolished by pretreatment with inhibitors of either FGFR1 or PI3kinase. Furthermore, α-klotho-mediated suppression of food intake, but not glucose levels, was blunted in response to inhibition of FGFR1 signaling.

Conclusion: These results indicate a prominent role of hypothalamic α-klotho-FGFR1-PI3K signaling in regulation of NPY/AgRP neuron activity, energy balance, and glucose homeostasis, thus providing new insight into the pathophysiology of metabolic disease.

Disclosure

T. Landry: None. P. Li: None. W.P. Bunner: None. Z. Rao: None. H. Huang: None.

Funding

East Carolina University

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.